Alopecia Areata Trial, Recruiting NCT05460611 Sponsor: Montefiore Medical Center Condition: Alopecia Areata
Back to Alopecia Areata

Alopecia Areata Trial, Recruiting

NCT05460611
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are male or female, aged 18 or older, and are looking for treatment for hair loss
  • You have been diagnosed with androgenetic alopecia (common pattern baldness) or scarring alopecia, confirmed by a biopsy, with hair loss recorded over the past 6 months
  • Your hair loss treatment has been stable for at least 3 months, with no further improvement during that time
  • You are willing and able to sign a consent form, showing you understand and agree to take part
  • You are considered healthy and have not smoked in the past 12 months, and agree not to change your current hair care routine during the study
  • You are able and willing to follow the treatment schedule and all study requirements
  • You agree not to have any other treatments done to the area being studied for the duration of the trial

Who may not be able to join:

  • You are unable to give your own consent to take part in the study
  • You have a different type of hair loss, such as alopecia areata (patchy hair loss)
  • You have had steroid injections into your scalp in the last 12 months
  • You are pregnant
  • You have a medical condition that may make you more sensitive to light treatments (confirm with trial site)
  • You have had a surgical procedure in the treatment area in the past 12 months, or any major surgery in the last 6 months
  • You have an allergy to lidocaine (a local anaesthetic) or have had a reaction to it before
  • You have a history of immune system disorders, including HIV or AIDS, or have had systemic chemotherapy in the past 12 months
  • You are currently taking or have recently taken certain prescription medications, including immune-suppressing drugs or biologics within the past 6 months, or Accutane (isotretinoin) or similar vitamin A-based medications within the past 12 months
  • You have smoked or vaped in the past 12 months
  • You have a history of uncontrolled high cholesterol, diabetes, hepatitis, or bleeding disorders
  • You have a history of major depression or thyroid/hormonal disorders, such as an underactive thyroid, Hashimoto's thyroiditis, or an overactive thyroid

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kseniya Kobets, MD, Albert Einstein College of Medicine Montefiore Medical Center

Phone: 618-704-8716

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Montefiore Medical Center
Registry
ClinicalTrials.gov
Start date
7 December 2023
Est. completion
1 July 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Live and Photographic assessment of hair loss; Hair Density; Hair Counts

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov